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ABSTRACT. Synthesis, heterocyclization and anticancer activity of a new series of heterocyclic compounds are 
described. Aminothiazine 1 was obtained from the base induced condensation of thiourea, benzaldehyde and ethyl 
cyanoacetate. The synthesis of N-phenyl amino pyrimidine derivative 2 was obtained as a result of reaction of 
aniline with compound 1. Compound 2 underwent ring opening and recyclization upon reaction with HCl or H2O2/ 
NaOH to afford the acid derivative 3 or oxazine 4, respectively. Thiazine 1 undergoes ring transformation upon 
the effect of NH2OH.HCl to produce pyrimidine derivative 5. Heterocyclization of compound 1 with 
thiosemicarbazide followed by oxidation with I2/AcOH afforded triazolopyrimidine 6 and 7, respectively. 
Alkylation of compound 1 was promoted by reaction of 1 with ethyl iodide to give alkylated thiazine 8 which in 
turn undergo ring transformation when subjected to reaction with hydrazine hydrate to give pyrazole derivative 9. 
Refluxing of amino-1,3-thiazine derivative 1 with ethyl bromoacetate in the presence of Et3N produce the 
alkylated pyrimidine product 10. Hydrazonolysis of 1,3-thiazine 1 with hydrazine or phenyhydrazine gave 
pyrimidine derivatives 11a,b, respectively. Compound 11b was cyclized with carbon disulfide or formaldehyde to 
produce triazolopyrimidines 12 and 13, respectively. Some of the new compounds were screened for anticancer 
activity and significant results were found for some compounds. 
  




1,3-Thiazine derivatives are class of compounds with potential biological activity, such as  
growth promoting activities [1], anti-fungal activity [2], antiproliferative [3], anti-tumor activity 
[4], anticancer [5], analgesic activity [6,7], calming activity [8], anticonvulsant activity [9], 
antibiotic alctivity [10, 11], anti-inflammatory [11, 12], antimicrobial [13], antimycobacterial 
[14], antibacterial [15] and antihypertesive [7, 16]. On the other hand, pyrimidine derivatives are 
known to be biologically active compounds and have shown wide range of biological activities 
like antitubercular [17], antimicrobial, antioxidant and anti-inflammatory [18-20], anticancer 
[21], analgesic, anti-fungal activity, anti-leishmanial, antiviral activity [22, 23]. Recently, our 
research field focused to design and synthesis of biologically active heterocyclic compounds 
from readily available reagents [24-26]. Herein, we hope to use a simple and facile approach to 
synthesize a novel series of heterocyclic systems utilizing 2-amino-4-oxo-4-phenyl-4H-1,3-




All melting points are uncorrected and were measured using an Electro thermal Al 9100 
apparatus. TLC was performed on Merck silica gel 60F245 with detection by UV light. The IR 
spectra (KBr disc) were recorded on a Pye Unicam Sp-3-300 or a Shimadzu FTIR 8101 PC 
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infrared spectrophotometer. The 1H and 13C NMR spectra were determined with JEOL-JNM- 
LA 300 MHZ spectrometer. The chemical shifts are expressed on the (ppm) scale using TMS as 
the standard reference. Elemental analysis determined on a Perkin Elmer 240 (microanalysis). 
The antitumor activity was performed at micro analytical center, Cairo Univeristy, Cairo, Egypt. 
     
2-Amino-4-oxo-4-phenyl-4H-1,3-thiazine-5-carbonitrile (1) 
 
A mixture of thiourea (0.01 mol), ethyl cyanoacetate (0.01 mo1), benzaldehyde (0.01 mol), and 
anhydrous potassium carbonate (0.01 mol) in absolute ethanol (25 mL) was heated under reflux 
for 6 hours. The reaction mixture was cooled and triturated with water and neutralized with 
glacial acetic acid, the formed precipitate was filtered, washed with water, dried and crystallized 
from acetic acid to give white crystals from 1, yield 65%, m.p. 296-300 oC. IR (KBr cm-1): 
3196, 3153 (NH2), 2232 (C≡N), 1688 (C=O). 
1H NMR (DMSO-d6, δ ppm): 7.32-7.68 (m, 5H, 
Ar-H), 13.07 (NH2). 
13C NMR (DMSO-d6, δ ppm): 90.5, 114.8 (C≡N), 128.4, 128.7, 129.6, 
132.0, 158.6, 161.1, 176.4 (Ar-C and C=O). Anal. calcd for C11H7N3OS (229.26): C, 57.63; H, 




To a solution of 1,3-thiazine 1  (0.01 mol) in n-butanol (30 mL), aniline (0.01 mol) was added, 
the reaction mixture was refluxed for 8 hours, the reaction mixture left to cool and kept at room 
temperature overnight, the formed precipitate was filtered off, dried and crystallized from 
ethanol to give yellow crystals from 2, yield 90%, m.p. 260-265 oC. IR (KBr cm-1): 3427 (NH2), 
2206 (C≡N), 1675 (C=O). 1H NMR (DMSO-d6, δ ppm): 7.49-7.69 (m, 10H, Ar-H), 12.56 (s, 
2H, NH2). 
13C NMR (DMSO-d6, δ ppm): 89.1, 92.3, 116.10 (C≡N), 126.3, 128.2, 128.5, 131.4, 
132.0, 133.1, 141.8, 159.8, 163.0 and 178.4 (Ar-H and C=O). Anal. calcd for C17H12N4O 
(288.30): C, 70.82; H, 4.20; N, 19.43. Found: C, 70.87; H, 4.26; N, 19.39. 
 
(Amino (phenylamino) methylene) amino)-2-cyano-3-phenylacrylic acid (3)  
 
2-Amino pyrimidine 2 (0.01 mol) in ethanol (20 mL) and concentrated hydrochloric acid (1 mL) 
was added, then refluxed for 3 hours, the resulting mixture was neutralized with sodium 
hydroxide solution, then concentrated and left to cool, the solid obtained was dried and washed 
by petroleum ether 60-80 oC to give yellow crystals from 3, yield 52%, m.p. > 300 oC. IR (KBr 
cm-1): 3410, 3172 (OH, NH), 2208 (C≡N), 1651 (C=O). 
1H NMR (DMSO-d6, δ ppm): 5.60 (s, 
2H, NH2), 7.41-7.73 (m, 10H, Ar-H), 10.0 (s, 1H, NH), 11.5 (s, 1H, OH). Anal. calcd for 




A mixture of 2-amino pyrimidine 2 (0.01 mol) and sodium hydroxide solution (20 mL) 
[prepared from NaOH (0.02 mol) in ethanol (20 mL)], hydrogen peroxide (1 mL) was added 
drop wise with stirring at room temperature for 2 hours, the reaction mixture was triturated with 
water and neutralized with concentrated hydrochloric acid and stirred, the resulting solid was 
dried and crystallized from methanol to give white crystals from 4, yield 40%, m.p. > 300 oC. IR 
(KBr cm-1): 3149 (NH), 2206 (C≡N), 1649 (C=O). 1H NMR (DMSO-d6, δ ppm): 7.41-7.68 (m, 
10H, Ar-H), 10.10 (NH). Anal. calcd for C17H11N3O2 (282.29): C, 70.58; H, 3.83; N, 14.33. 
Found: C, 70.56; H, 3.77; N, 14.29. 
 
2-Amino-1-hydroxy-4-oxo-6-phenyl-1,4-dihydropyrimidine-5-carbonitrile (5)  
 
A mixture of 2-aminothiazine 1 (0.01 mol), hydroxylamine hydrochloride (0.02 mol), and (3 
drops) of triethyl amine. in n-butanol (20 mL) was refluxed for 8 hours, after cooling, the 
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formed  precipitate was filtered off, dried and crystallized by acetic acid to give brown crystals 
from 5, yield 77%,  m.p. > 310 oC. IR (KBr cm-1): 3427 (OH, NH2), 2210 (C≡N), 1635 (C=O). 
1H NMR (DMSO-d6, δ ppm): 6.95 (s, 2H, NH2), 7.50-7.79 (m, 5H, Ar-H), 11.69 (s, 1H, OH). 
13C NMR (DMSO-d6, δ ppm): 84.7, 117.1 (C≡N), 128.1, 128.2, 130.8, 136.5, 156.3, 161.5 and 
171.5 (Ar−C and C=O). Anal. calcd for C11H8N4O2 (228.21): C, 57.89; H, 3.53; N, 24.55. 




A mixture of 2-aminothiazine 2 (0.01 mol), thiosemicarbazide  (0.01 mol), and  (3 drops ) of 
triethylamine in n-butanol (20 mL) was refluxed for 6 hours, the reaction mixture was kept at 
room temperature overnight, the precipitate obtained was filtered off, dried and crystallized 
from ethanol to yield yellow crystals from 6, yield 68%, m.p. 220-226 oC. IR (KBr cm-1): 3376 
(NH), 2213 (C≡N), 1622 (C=O), 1233 (SH). 1H NMR (DMSO-d6, δ ppm): 7.51-7.71 (m, 5H, 
Ar-H), 8.61 (s, 1H, NH), 12.25 (s, 1H, SH). Anal. calcd for C12H7N5OS (269.28): C, 53.52; H, 
2.62; N, 26.01. Found: C, 53.56; H, 2.59; N, 25.95.   
 
6-Cyano-5-oxo-7-phenyl-1,5-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonic acid (7)  
 
A mixture of pyrimidine derivative 6 (0.01 mol) and iodine (0.01 mol) in glacial acetic acid (20 
mL) was sterrid for 2 hours, the formed precipitate was filtered off, washed with water, dried 
and crystallized by ethanol to yield white crystals  from 7, yield 78%, m.p. 310-312 oC. IR (KBr 
cm-1): 3448 (OH, NH), 2230 (C≡N), 1679 (C=O). 1H NMR (DMSO-d6, δ ppm): 7.54-7.68 (m, 
5H, Ar-H), 13.17 (s, 1H, NH), 13.31 (s, 1H, OH). Anal. calcd for C12H7N5O4S (317.28): C, 
45.43; H, 2.22; N, 22.07. Found: C, 45.38; H, 2.27; N, 22.13. 
 
2-(Diethylamino)-4-oxo-6-phenyl-4H-1,3-thiazine-5-carbonitrile (8)  
 
A mixture of 2-aminothiazine 1 (0.01 mol), ethyl iodide (0.01 mol), and sodium hydroxide 
solution [prepared from sodium hydroxide (0.01 mol) in ethanol (30 mL) was refluxed for 3 
hours, after cooling, the reaction mixture was triturated with water and neutralized with 
concentrated hydrochloric acid, the resulting precipitate was filtered off, dried and crystallized  
from ethanol to give white crystals from 8, yield 69%, m.p. 230-235 oC .IR (KBr cm-1): 2218 
(C≡N), 1657 (C=O).1H NMR (DMSO-d6, δ ppm): 1.32 (t, 3H, CH2CH3), 3.25 (q, 2H, CH2CH3),  
7.29-7.95  (m, 5H, Ar-H). Anal. calcd for C15H15N3OS (285.36): C, 63.13; H, 5.30; N, 14.73. 




A mixture of 2-amino thiazine 8 (0.01 mol), hydrazine hydrate (0.01 mol) in n-butanol (20 mL) 
was refluxed for 10 hours, after cooling, the formed precipitate was filtered off, dried and 
crystallized from ethanol/acetic acid to give yellow crystals from 9 yield 77 %, m.p.267-270 oC. 
IR (KBr cm-1): 3436 (NH), 2221 (C≡N), 1646 (C=O).1H NMR (DMSO-d6, δ ppm): 7.47-7.78 
(m, 5H, Ar-H), 9.84 (m, 2H, 2NH, D2O exchangeable). Anal. calcd for C10H7N3O (185.06): C, 
64.86; H, 3.81; N, 22.69.  Found: C, 64.91; H, 3.75; N, 22.75.   
 
Diethyl-2,2`-((5-cyano-4-oxo-6-phenyl-4H-1,3-thiazin-2-yl)azanediyl) diacetate (10) 
 
A mixture of 2-aminothiazine 1 (0.01 mol), ethyl bromoacetate (0.01 mol), and (3 drops) of   
triethylamine  in ethanol (25 mL) was refluxed for 6 hours,  the resulting precipitate was filtered 
off, washed with water, dried and crystallized from ethanol to give yellow crystals of 10, yield 
80%, m.p. 224-230 oC. IR (KBr cm-1): 2223 (C≡N), 1735 (C=O, ester), 1661 (C=O, amide). 1H 
NMR (DMSO-d6, δ ppm): 1.11 (t, 3H, J = 5.7 Hz, CH2CH3), 2.50 (s, 2H, CH2), 4.08 (q, 2H, J = 
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5.7 Hz, CH2CH3), 7.54-7.92 (m, 5H, Ar-H). 
13C NMR (DMSO-d6, δ ppm): 13.8 (CH3CH2), 32.9 
(NCH2CO), 61.3 (OCH2CH3), 94.3, 115.6 (C≡N), 127.1, 128.5, 128.6, 129.8, 131.8, 138.0, 
165.7 and 167.9 (ArC and 2 C=O). Anal. calcd for C19H19N3O5S (401.44): C, 56.85; H, 4.77; 
N, 10.47. Found: C, 56.92; H, 4.81; N, 10.40.   
 
1,2-Diamino-4-oxo-6-phenyl-1,4-dihydropyrimidine-5-carbonitrile (11a)  
 
To a solution of 1,3-thiazine 1 (0.0.1 mol) in n-butanol (30 mL), hydrazine hydrate (0.02 mol) 
was added, the reaction mixture was refluxed for 8 hours, the reaction mixture left to cool and 
kept at room temperature overnight, the formed precipitate was filtered off, dried and 
crystallized from ethanol to give orange crystals from 11a, yield 87%, m.p. 236-243 oC. IR (KBr 
cm-1): 3456, 3221 (2NH2), 2218 (C≡N), 1652 (C=O). 
1H NMR (DMSO-d6, δ ppm): 7.15 (s, 2H, 
NH2), 7.45-7.78 (m, 5H, Ar-H), 9.85 (s, 2H, NH2). Anal. calcd for C11H9N5O (227.22): C, 58.14; 
H, 3.99; N, 30.82. Found: C, 58.07; H, 3.91; N, 30.87.  
   
2-Amino-4-oxo-6-phenyl-1-(phenylamino)-1,4-dihydropyrimidine-5-carbonitrile (11b) 
 
To a solution of 1,3-thiazine 1 (0.01 mol) in n-butanol (30 mL), phenyl hydrazine (0.01 mol) 
was added, the reaction mixture was refluxed for 12 hours, the reaction mixture left to cool and 
kept at room temperature overnight, the formed precipitate was filtered off, dried and 
crystallized from ethanol to give brown crystals from 11b, yield 80%, m.p. 246-252 oC. IR (KBr 
cm-1): 3427, 3293, 3139 (NH, NH2), 2206 (C≡N), 1634 (C=O).
 1H NMR (DMSO-d6, δ ppm): 
7.74-8.08 (m, 10H, Ar-H), 10.38 (s, 2H, NH2), 11.76 (S, 1H, NH).
 13C NMR (DMSO-d6, δ 
ppm): 112.9, 117.2 (C≡N), 118.1, 119.8, 122.7, 128.0, 128.2, 128.3, 129.5, 130.4, 131.0, 136.3, 
161.8 and 181.7 (ArC and C=O). Anal. calcd for C17H13N5O (303.32): C, 67.32; H, 4.32; N, 
23.09. Found: C, 67.41; H, 4.25; N, 23.13.    
 
2-Mercapto-5-oxo-1,7-diphenyl-1,5-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonitrile 
 (12)  
 
To ethanolic potassium hydroxide solution (20 mL) [prepared from KOH (0.01 mol) in ethanol 
(20 mL)], was added pyrimidine derivative 11b (0.01 mol) and carbon disulfide (0.01 mol), the 
reaction mixture was refluxed for 6 hours, the formed precipitate was filtered off, dried and 
crystallized from ethanol to give white crystals from 12, yield 66%, m.p. > 300 oC. IR (KBr   
cm-1): 3440 (NH), 2231 (C≡N), 1680 (C=O). 
1H NMR (DMSO-d6, δ ppm): 7.54-7.67 (m, 10H, 
Ar-H), 13.17 (s, 1H, SH). Anal. calcd for C18H11N5OS (345.38): C, 62.60; H, 3.21; N, 20.28. 
Found: C, 62.68; H, 3.16; N, 20.35. 
 
 5-Oxo-1,7-diphenyl-1,2,4,5-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonitrile (13) 
 
To ethanolic sodium hydroxide solution (20 mL) [prepared from NaOH (0.01 mol) in ethanol 
(20 mL)], was added pyrimidine derivative 11b (0.01 mol) and formaldehyde (0.01 mol). The 
reaction mixture was refluxed for 6 hours, the formed precipitate was filtered off, dried and 
crystallized from ethanol to give brown crystals from 13 yield 48%, m.p. >300 oC. 1H NMR 
(DMSO-d6, δ ppm): 3.32 (s, 2H, CH2), 7.56-8.30 (m, 10H, Ar-H), 11.85 (s, 1H, NH). Anal. 




Reagents. Fetal bovine serum (FBS) and L-glutamine were from Gibco Invitrogen Co. 
(Scotland, UK). RPMI-1640 medium was from Cambrex (New Jersey, USA). Doxorubicin, 
dimethyl sulfoxide (DMSO), penicillin, streptomycin and sulforhodamine B (SRB) were from 
Sigma Chemical Co. (Saint Louis, USA). 
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Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung 
cancer), and SF-268 (CNS cancer) were used. MCF-7 was obtained from the European 
Collection of Cell Cultures (ECACC, Salisbury, UK) and NCI-H460 and SF-268 were kindly 
provided by the National Cancer Institute (NCI, Cairo, Egypt). They grow as monolayer and 
routinely maintained in RPMI-1640 medium supplemented with 5% heat inactivated FBS, 2 
mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 μg/mL) at 37 oC in a 
humidified atmosphere containing 5% CO2. Exponentially growing cells were produced by 
plating 1.5 x 105 cells/mL for MCF-7, SF-268 and 0.75 x 104 cells mL-1 for NCI-H460, followed 
by 24 h of incubation. The effect of the vehicle solvent (DMSO) on the growth of cell lines 
which it was evaluated in all experimental by exposing untreated control cells to the maximum 
concentration (0.5%) of DMSO used in each assay. 
 
Tumor cell growth assay 
 
The effects of the newly synthesized compounds 2, 5, 10 and 11b on the in vitro growth of 
human tumor cell lines were evaluated according to the procedure adopted by the National 
Cancer Institute (NCI, USA) in the ‘In vitro Anticancer Drug Discovery Screen’ that uses the 
protein-binding dye sulforhodamine B to assess cell growth [27, 28]. Briefly, exponentially cells 
growing in 96-well plates were then exposed for 48 h to five serial concentrations of each 
compound starting from a maximum concentration of 150 μM. Following this exposure period 
adherent cells were fixed, washed and stained. The bound stain was solubilized and the 
absorbance was measured at 492 nm in a plate reader (Bio-Tek Instruments Inc., Power wave 
XS, Wincoski, USA). For each test compound and cell line, a dose response curve was obtained 
and the growth inhibition of 50% (GI50), corresponding to the concentration of the compounds 
that inhibited 50% of the net cell growth was calculated as described elsewhere. Doxorubicin 
was used as a positive control and tested in the same manner. 
 
RESULTS AND DISCUSSION 
 
In the present work, it is intended to investigate the synthetic possibilities of novel 2-amino-4-
oxo-4-phenyl-4H-1,3-thiazine-5-carbonitrile and its transformation to pyrimidine and condensed 
systems, The anticancer properties of the prepared compounds were screened in an attempt to 
determine new heterocyclic agents which could be useful as a hint in a drug discovery program. 
One pot multicomponent reaction of benzaldehyde, thiourea and ethyl cyanoacetate in 
ethanolic potassium carbonate resulted in 1,3-thiazine cyclization affording aminocyano- 
thiazinone derivative 1 as a kinetic controlled product (Scheme 1). The structure of 
aminothiazine 1 was supported  by  1H NMR which revealed signal at   13.07 ppm  for NH2  
and  multiplet  at δ 7.32-7.68 ppm for  aromatic protons. The IR spectrum also showed the 
functional groups C≡N and C=O at 2232 cm-1 and 1688 cm-1, respectively. In addition to two 
bands at 3196 and 3153 cm-1 for NH2 group. The structure of aminothiazine 1 was also 
potentiated by ring transformation to pyrimidine derivatives by the effect of nitrogen 
nucleophile. The synthesis of the more stable product known as N-phenylaminopyrimidine 
derivative 2 was obtained as a result of the nucleophilic reaction of aniline with cyano-1,3-
thiazine derivative 1 in n-butanol (Scheme 1). 
IR spectrum of 2 showed bands at 3427 cm-1, 2206 cm-1 and 1675 cm-1 for NH2, C≡N and 
C=O groups, respectively. Its 1H NMR spectrum displayed signals at δ 12.56 ppm for NH2 and 
7.49-7.69 ppm for aromatic protons. Compound 2 suffer acid induced ring opening upon 
treatment with HCl to produce the acid derivative 3 (Scheme 1). Its IR spectrum showed 
absorption bands at 3410, 3172, 2208 and 1651 cm-1 corresponding to OH, NH C≡N and C=O 
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groups, respectively. 1H NMR spectrum showed signals at δ 11.5 ppm for OH, 10.0 ppm for 
NH, and 7.41-7.73 ppm for aromatic protons. Also oxidative ring opening of cyanopyrimidine 2 
was achieved by keeping compound 2 in H2O2 in the presence of NaOH in one pot flask to 
produce oxazine 4 (Scheme 1). Its IR spectrum showed bands at 3149 cm-1 for NH and 2206, 
1649 cm-1 for C≡N and CO respectively. 1H NMR spectrum showed signal at δ 10.10 ppm for 
NH and 7.41-7.68 ppm for aromatic protons.  Cyanothiazine derivative 1 undergo ring cleavage 
followed by heterocyclization producing N-hydroxypyrimidine derivative 5 in good yield (77%) 
upon reaction with hydroxyl amine hydrochloride (Scheme 2). The structure was agreement 
with the spectral data (see the experimental section). 
 
  
Scheme 1. Synthesis and reaction of 1,3-thiazine derivative 1. 
 
Triazolopyrimidine of type 6 was prepared upon the reaction of thiazine derivative 1 with 
thiosemicarbazide in the presence of triethylamine (Scheme 2). IR spectra showed absorption 
bands at 3376 cm-1 for NH, 2213 cm-1 for C≡N, 1622 cm-1 for CO, and 1233 cm-1 for SH. 1H 
NMR spectrum showed signals at	  12.25 ppm for SH, 8.61 ppm for NH, and 7.51-7.71 ppm for 
aromatic protons. Compound 6 was transformed to the sulphonic acid derivative 7 by the 
oxidation with I2/AcOH 
Compound 1 undergo N-alkylation upon the effect of ethyl iodide in presence of NaOH to 
give 8, which undergo ring opening followed by heterocyclizayion to give pyrazolone 9 upon 
treating with hydrazine hydrate (Scheme 2). The IR spectrum of 9 showed absorption bands at 
3436 cm-1 for NH, 2221 cm-1 for C≡N, and 1646 cm-1for C=O. 1H NMR spectrum showed 
multiplet at 9.84 ppm for 2NH protons  and  multiplet at  7.47- 7.78 ppm for aromatic protons.  
Upon refluxing of  amino-1,3-thiazine derivative 1  and ethyl bromoacetate in the presence 
of  triethyl amine resulted N-alkylation producing  bis-N(ethoxy carbonyl methyl) thiazine 
derivative 10 (Scheme 2). IR spectrum showed absorption bands at 2223 cm-1, 1735 cm-1, and 
1661cm-1 for C≡N, C=O ester and C=O amide respectively. 1H NMR spectrum showed down 
field multiplet signal at δ 7.54-7.92 ppm for aromatic protons, quartet signal at 4.08 ppm for 
CH2CH3 and triplet at 1.11 ppm for CH2CH3 protons, in addition to singlet at 2.5 ppm 
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corresponding to NCH2CO protons. The refluxing of 1,3-thiazine derivative 1 and hydrazine 
hydrate or phenyl hydrazine resulted in ring transformation affording diaminopyrimidine 
derivatives 11a,b, respectively (Scheme 2). The IR spectrum of 11a showed absorption bands at 
3456, 3221 cm-1 for NH2 groups, 2218 cm
-1 for C≡N group, and 1652 cm-1 for C=O group. 1H 
NMR spectrum showed signal at δ 7.15 and 9.85 ppm for 2NH2, in addition to aromatic protons 
at 7.45-7.78 ppm. The IR spectrum of 11b showed bands at 3139 cm-1 for NH, NH2, 2206 cm
-1 
for C≡N and 1634 cm-1for C=O, its 1H NMR showed signal at	  11.76 ppm, 10.38 ppm for NH 
and NH2, and 6.74-8.08 ppm for aromatic protons. Compound 11b bearing of suitably located 
functionality for further cyclization, thus intremolecular cyclization of diaminopyrimidine 
derivative 11b with carbon disulphide afforded triazolopyrimidine derivative 12 (Scheme 2). IR 
spectrum of 12 showed bands at 3440, 2231, and 1680 cm-1 for NH, C≡N, and C=O, 
respectively. Its 1H NMR spectrum showed signal at δ 13.17 ppm for SH and 7.54-7.70 ppm for 
aromatic protons. Using formaldehyde as cyclizing agent aiming to obtain triazole derivative 13 
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Scheme 2. Heterocyclization of 1,3-thiazine derivative 1. 
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The results of anticancer activity are given in concentrations that were able to cause 50% of cell 
growth inhibition (GI50) after a continuous exposure of 48 hours  and show means ± SEM of 
three independent experiments performed in duplicate (Table 1). Where diethyl-2,2`-((5-cyano-
4-oxo-6-phenyl-4H-1,3-thiazin-2-yl)azanediyl) diacetate (10) showed the highest inhibitory 
effects against all three tumor cell lines. Such activity is not higher than the corresponding 
reference doxorubicin, while 2-amino-6-oxo-1,4-diphenyl-1,6-dihydropyrimidine-5-carbonitrile 
(2), 2-amino-1-hydroxy-4-oxo-6-phenyl-1,4-dihydropyrimidine-5-carbonitrile (5) and 2-amino-
4-oxo-6-phenyl-1-(phenylamino)-1,4-dihydropyrimidine-5-carbonitrile (11b) showed lower 
inhibitory effect. It is obvious that by comparing the structures of the four compounds, we found 
that the presence of thiazine ring system substituted with bis-N-(ethoxy carbonyl methyl) is 
responsible for their reactivity over the compounds 2, 5 and 11b, on the other hand, we can 
observe the presence of NH2 in compounds 2, 5 and 11b decrease the anticancer activity. 
 





NCI-H460 MCF-7 SF-268 
2 55.3± 8.7 60.0  ±10 60.0  ± 10 
5 28.2 ± 3.4 18.3 ± 4.2 18.3 ± 4.2 
10 12.4 ± 2.3 8.33 ± 1.2  8.33 ± 1.2  
11b 8.36 ± 1.34 30.1 ± 10 30.1 ± 10 
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